PDL BioPharma, Inc. Income tax paid

Income tax paid of PDLI for past 10 years: annual, quarterly and twelve month trailing (TTM) including Income tax paid growth rates and interactive chart.


Highlights and Quick Summary

  • Income tax paid for the quarter ending December 30, 2019 was $0 (a -100.0% decrease compared to previous quarter)
  • Year-over-year quarterly Income tax paid decreased by -100.0%
  • Annual Income tax paid for 2019 was $1 Thousand (a -100.07% decrease from previous year)
  • Annual Income tax paid for 2018 was $-1.36 Million (a -59.32% decrease from previous year)
  • Annual Income tax paid for 2017 was $-3.35 Million (a -347.49% decrease from previous year)
  • Twelve month Income tax paid ending December 30, 2019 was $15 Thousand (a -125.0% decrease compared to previous quarter)
  • Twelve month trailing Income tax paid decreased by -101.76% year-over-year
Trailing Income tax paid for the last four month:
30 Dec '19 29 Sep '19 29 Jun '19 30 Mar '19
$15 Thousand $-60 Thousand $-188 Thousand $-851 Thousand
Visit stockrow.com/PDLI for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Income tax paid of PDL BioPharma, Inc.

Most recent Income tax paidof PDLI including historical data for past 10 years.

Interactive Chart of Income tax paid of PDL BioPharma, Inc.

PDL BioPharma, Inc. Income tax paid for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2019 $0.0 $0.0 $0.01 $0.01 $0.0
2018 $-0.08 $-0.13 $-0.65 $-0.51 $-1.36
2017 $-5.78 $-7.85 $5.69 $4.59 $-3.35
2016 $-1.07 $-4.0 $-11.23 $17.65 $1.35
2015 $3.37 $0.0 $0.0 $-3.29 $0.08
2014 $-3.2 $-4.32 $5.48 $5.34 $3.29
2013 $-15.52 $18.75
2012 $18.59
2011 $12.58
2010 $24.39

Business Profile of PDL BioPharma, Inc.

Sector: Other
Industry: Other
PDL BioPharma, Inc. manages various patents in the United States and internationally. The company's patents cover humanization of antibodies. It also offers notes and other long-term receivables services, as well as engages in the equity investment activities. The company was formerly known as Protein Design Labs, Inc. and changed its name to PDL BioPharma, Inc. in 2006. PDL BioPharma, Inc. was founded in 1986 and is headquartered in Incline Village, Nevada.